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Abstract Transferrin binding protein A (TbpA) is a TonB-de-
pendent outer membrane protein expressed by pathogenic bac-
teria for iron acquisition from human transferrin. The N-termi-
nal 160 residues (plug domain) of TbpA were overexpressed in
both the periplasm and cytoplasm of Escherichia coli. We found
this domain to be soluble and monodisperse in solution, exhibit-
ing secondary structure elements found in plug domains of struc-
turally characterized TonB-dependent transporters. Although
the TbpA plug domain is apparently correctly folded, we were
not able to observe an interaction with human transferrin by
isothermal titration calorimetry or nitrocellulose binding assays.
These experiments suggest that the plug domain may fold inde-
pendently of the L-barrel, but extracellular loops of the L-barrel
are required for ligand binding.
& 2004 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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1. Introduction
The Gram-negative genus Neisseria contains two pathogen-
ic species, N. gonorrhoeae and N. meningitidis, the causative
agents of gonorrhea and meningitis, respectively. Humans are
the only hosts for these pathogens, possibly because Neisseria
can only acquire iron e⁄ciently from the human iron binding
proteins hemoglobin, hemoglobin-haptoglobin [1^6], transfer-
rin (hTf), and lactoferrin [1,7^12]. These host iron binding
proteins have very high a⁄nities for iron, thus reducing the
level of free iron available for bacterial growth. Most bacteria
synthesize and secrete low molecular weight siderophores,
which also have high a⁄nities for iron and are thus capable
of competing for iron with host iron binding proteins [13].
Ferric siderophores are bound and transported into the peri-
plasm by speci¢c transporters in the outer membrane [14]. The
transport mechanism appears to require proton motive force
and a functional TonB-ExbB-ExbD complex, making it an
active transport process [15]. In contrast to this mechanism
of iron uptake, the pathogenic Neisseria species do not secrete
siderophores [16^19] but express outer membrane proteins
that bind and obtain iron directly from host iron proteins
[20]. This process involves direct contact between the host
iron protein and the outer membrane of the pathogen
[17,18,21], as well as proton motive force and a neisserial
TonB-ExbB-ExbD complex [22]. Iron uptake from hTf is
mediated by the iron-repressible outer membrane complex,
transferrin binding proteins A and B (TbpA and TbpB) [23].
TbpA (100 kDa) is an integral outer membrane protein and is
well conserved among all strains of pathogenic Neisseria spe-
cies [24]. TbpB is variable in size (68^85 kDa) and is a surface-
exposed lipoprotein [25]. Each protein is capable of binding
hTf independently, although the binding e⁄ciency is increased
in the presence of a TbpA-TbpB complex [26]. While TbpB is
not required for iron uptake, TbpA serves as the channel for
entry of iron into the cell and is therefore absolutely required
[27].
TbpA has been proposed to fold similarly to FepA (ferric
enterobactin transporter) and FhuA (ferric hydroxamate
transporter), two Escherichia coli TonB-dependent sidero-
phore transporters [28]. The crystal structures of FepA [29]
and FhuA [30,31] show that each protein is composed of
two domains: a 22-stranded L-barrel with large extracellular
loops is embedded in the outer membrane, and an N-terminal
globular domain is inserted into the barrel from the periplas-
mic side. Recently, the crystal structures of two additional
E. coli TonB-dependent transporters, the ferric citrate trans-
porter FecA [32,33] and the cobalamin transporter BtuB [34],
were reported and are similar to the FepA and FhuA struc-
tures. Hence, it is anticipated that all TonB-dependent trans-
porters will adopt the same basic two-domain architecture.
TonB-dependent transporters possess seven conserved re-
gions [35], which have also been identi¢ed in TbpA [25,36].
One of these regions is referred to as the TonB box, a penta-
peptide sequence located on the periplasmic side of the N-ter-
minal domain (Fig. 1). The TonB box of the transporter is
postulated to physically interact with TonB [37^41], resulting
in transduction of energy from the inner membrane (derived
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from the proton gradient across the inner membrane) to the
outer membrane transport proteins. TonB contains a single
membrane-spanning K-helix, which anchors it in the inner
membrane, and a large periplasmic domain, which interacts
with the outer membrane transporter. The integral inner
membrane proteins ExbB and ExbD interact with TonB,
and are required for optimal energy transduction [42]. Con-
sistent with other TonB-dependent transporters, gonococcal
TbpA has also been demonstrated to interact with TonB
[22]. Mutations in the TonB box of TbpA abolish iron trans-
port, although TbpA is still able to bind hTf [43]. This dem-
onstrates that TonB is required for transport of iron from hTf
across the outer membrane.
The N-terminal domain of TonB-dependent transporters
consists of a central four-stranded L-sheet, with several K-heli-
ces, L-strands and loops making up the rest of the structure
(Fig. 1). It contains two (FepA), three (FhuA, FecA), or four
(BtuB) loops that are positioned above the extracellular side
of the lipid bilayer; residues from these loops form the £oor
of the binding pocket for the recognized ligand. The majority
of the binding pocket is composed of residues from the extra-
cellular loops of the barrel. The N-terminal domain com-
pletely blocks the L-barrel, making over 60 hydrogen bonds
and numerous (nine or more) salt bridges with the L-barrel
and extracellular loops. For this reason, it has been referred to
as the plug [31], cork [30] or hatch [29] domain. Binding of
ligand causes conformational changes in the plug domain,
beginning with small changes at the extracellular side of the
transporter that are propagated across the plug domain, with
larger changes observed for residues at the periplasmic side of
the transporter. The structures of FhuA and FecA in complex
with their respective ligands reveal that a short K-helix, re-
ferred to as the switch helix (which is immediately preceded
by the TonB box), unwinds and becomes disordered, possibly
extending into the periplasm. This movement is suggested to
bring the TonB box into contact with TonB. A FhuA mutant,
in which the plug domain was constrained within the barrel
via a disul¢de bond, was incapable of transporting FhuA
substrates [44], con¢rming the importance of the plug domain
for ligand transport. However, none of the crystal structures
reveals how the ligand is eventually transported. Siderophores
range in size from 400 to 1500 Da, with ferric enterobactin
(700 Da) having a radius of about 10 AM . Somehow the trans-
porter must change its conformation to create a channel of
the appropriate size, allowing bound ligand to be transported.
Current hypotheses suggest a conformational rearrangement
of the plug while it remains within the barrel [30,45] or com-
plete removal of the plug from the barrel [46]. Expression of
the FepA plug domain in the absence of its L-barrel yielded a
polypeptide that was predominantly unfolded, but bound its
cognate ligand with an a⁄nity reduced by only 100-fold [47].
These authors therefore suggested that the fold of the plug
domain might be only marginally stable, allowing the plug
domain to unfold during ligand transport, thus facilitating
either of the two hypothesized mechanisms.
While the mechanism of ligand transport remains unknown,
recent results from di¡erential scanning calorimetry shed light
on the folding behavior of the plug domain. Studies on FhuA
suggest that the plug domain and the L-barrel behave as
autonomous domains that unfold independently [48]. FhuA
was observed to undergo two melting transitions at temper-
atures of 65‡C and 75‡C, corresponding to unfolding of the
plug domain (plus portions of extracellular loops of the L-bar-
rel) at the lower temperature, followed by unfolding of the
L-barrel at the higher temperature. The ¢rst unfolding event
was reversible, indicating that the plug domain may be able to
fold (or refold) independently of the L-barrel.
To better understand the folding and ligand binding capa-
bilities of a plug domain in the absence of its L-barrel, we
have expressed the ¢rst 160 residues of TbpA from N. menin-
gitidis (TbpA160) and characterized it by analytical ultracen-
trifugation, circular dichroism (CD) spectroscopy, and ligand
binding analyses. Our results suggest that the plug domain has
the expected secondary structure content when expressed in
the cytoplasm or periplasm of E. coli, and the puri¢ed protein
is monomeric and monodisperse in solution. TbpA160 does
not bind hTf when analyzed by nitrocellulose binding assays
or isothermal titration calorimetry, suggesting that the bind-
ing site for hTf is primarily composed of residues from the
L-barrel domain.
2. Materials and methods
2.1. Cytoplasmic and periplasmic expression of the N-terminal domain
of TbpA
The DNA encoding the N-terminal domain of TbpA (TbpA160)
from N. meningitidis strain K454 (B:15:P1.7,16) was ampli¢ed by
polymerase chain reaction (PCR) with Pfu polymerase (Stratagene)
using the full-length tbpA gene as template. For cytoplasmic expres-
Fig. 1. Ribbon diagram of unliganded FecA prepared from the co-
ordinates of the crystal structure [33]. The extracellular space is to-
ward the top of the ¢gure, and the periplasmic space is toward the
bottom of the ¢gure. The front L-strands of the barrel domain (yel-
low) have been removed to reveal the plug domain (blue) and the
TonB box (red). The residues highlighted in green (F147 and G148)
correspond to TbpA residues Y75 and S76. This ¢gure was pre-
pared with MOLMOL [65].
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sion, the ampli¢ed fragment, encoding an N-terminal 10 histidine tag,
was cloned into the expression vector pET17b (Novagen) using the
NdeI and HindIII restriction sites. For periplasmic expression, a frag-
ment was ampli¢ed by PCR corresponding to TbpA160, including an
in-frame 5P EcoRV recognition site and codons for 10 histidine resi-
dues at the N-terminus. The fragment was cloned into the EcoRV and
HindIII restriction sites of pET20b (Novagen), which contains a pelB
signal sequence and allows for periplasmic expression of TbpA160.
E. coli BL21(DE3) (Novagen) competent cells were transformed with
the resultant vectors.
2.2. Expression and puri¢cation of TbpA160 targeted to the cytoplasm
or periplasm
For cytoplasmic expression of TbpA160, recombinant bacteria were
grown in 2 l Luria broth, supplemented with carbenicillin (¢nal con-
centration 100 Wg/ml) at 30‡C or 37‡C under non-inducing conditions,
to OD600 = 3^4. For periplasmic expression, recombinant bacteria
were grown in 9 l of Terri¢c Broth (supplemented with carbenicillin
as described above) at 20‡C under non-inducing conditions, to
OD600 = 8^10.
For both constructs, cells were harvested by centrifugation at
2500Ug, 4‡C for 30 min. Harvested cells (20 g) were resuspended in
cold bu¡er containing 20 mM Tris^HCl, pH 8.0, 200 mM NaCl, and
0.4 mM AEBSF, and thoroughly mixed with a Dounce homogenizer.
Next, 10 mM MgCl2 and 100 Wg/ml DNase I were added and the cell
suspension was stirred at 4‡C for 30 min. The cells were disrupted at
4‡C using a French pressure cell at 18 000 psi (two passes). The cell
lysate was centrifuged for 1 h at 39 000Ug, yielding insoluble (pellet)
and soluble (supernatant) fractions. The pellet and supernatant were
analyzed for recombinant protein expression by sodium dodecyl sul-
fate^polyacrylamide gel electrophoresis (SDS^PAGE) [49]. For peri-
plasmic expression, the periplasmic fraction was isolated by osmotic
shock as described in the pET System Manual (Novagen).
For TbpA160 expressed in either the cytoplasm or periplasm, the
supernatant was applied to a 10 ml nickel-nitrilotriacetate a⁄nity
column (Ni-NTA; Qiagen) at 4‡C or room temperature, equilibrated
with 50 mM NaPi, pH 8.0, 200 mM NaCl, 30 mM imidazole, 10% (v/
v) glycerol. The bound protein was eluted using a step gradient at 250
mM imidazole. The resulting peak fractions were pooled and concen-
trated using a YM10 ultra¢ltration membrane (Millipore) and applied
to a Sephacryl S-100 16/60 column (Amersham Biosciences) at 4‡C or
room temperature, equilibrated with 20 mM Tris^HCl, pH 8.0, 200
mM NaCl, 1 mM EDTA, 0.02% (w/v) NaN3. Eluted protein fractions
were analyzed for purity by SDS^PAGE. Final protein concentrations
were determined by relating absorbance readings at 280 nm to the
calculated TbpA160 extinction coe⁄cient of 5120 M31 cm31. When
necessary, a protease inhibitor cocktail consisting of 100 mM AEBSF,
80 WM aprotinin, 5 mM bestatin, 1.5 mM E-64, 7.5 mM phosphor-
amidon and 1 mM pepstatin A (Sigma) was added to all bu¡ers at a
ratio of 1:1000 (v/v).
2.3. Mass spectroscopy
Mass spectra were collected on a Micromass Platform single-quad-
rupole mass spectrometer (Micromass, Whatman, Altrincham, UK).
A 10 Wl sample was injected and the delivery solvent (50% (v/v) ace-
tonitrile/50% water) was pumped at 10 Wl/min. Twelve 10 s scans in
positive ion mode were accumulated for each sample. The source
temperature was set at 323 K. Spectra were processed using the Mass-
lynx software supplied by Micromass (version 3.4).
2.4. Mutagenesis experiments
Mass spectroscopic analysis indicated a single proteolytic cleavage
site between residues Y75 and S76 of TbpA160. Four mutations were
introduced to prevent proteolysis: TbpA160-vY75, TbpA160-vS76,
TbpA160-vY75S76 and TbpA160-Y75F. Mutagenesis experiments
were carried out with the QuikChange Site-Directed Mutagenesis
Kit (Stratagene) using the pET17b vector bearing the TbpA160 cod-
ing sequence as a template. The TbpA160 mutants thus obtained were
veri¢ed by DNA sequencing (MWG, High Point, NC, USA) and
expressed, puri¢ed and analyzed as previously described.
2.5. Analytical ultracentrifugation
Sedimentation equilibrium experiments were conducted at 4‡C on a
Beckman Optima XL-A analytical ultracentrifuge. A sample of
TbpA160 (wild-type) was dialyzed against 200 mM NaCl and
20 mM Tris^HCl, pH 7.2, and the absorbance was adjusted to
A280 = 0.85. A 160 Wl sample was loaded into the cuvette and analyzed
at di¡erent rotor speeds, ranging from 16 000 to 20 000 rpm. Data
were acquired as an average of four absorbance measurements at a
nominal wavelength of 280 nm and a radial spacing of 0.001 cm.
Equilibrium was achieved within 48 h. Data were analyzed in terms
of a single ideal solute to obtain the buoyant molecular mass,
M1(13X1b), using the Optima XL-A data analysis software (Beck-
man) running under Microcal Origin 3.78, by ¢tting data from each
scan to:
Ar ¼ Ao;1 exp½HM1ð13X 1b Þðr23r2oÞ þ E
where Ao;1 is the absorbance at a reference point ro, Ar is the absor-
bance at a given radial position r, H represents g2/2RT, g the angular
speed in rad31, R is the gas constant, T is the absolute temperature
and E is a small baseline correction. Residuals were calculated. A
random distribution of the residuals around zero ( U 0.02) was ob-
tained as a function of the radius. Values of M1 were obtained
from the buoyant molecular mass, M1(13X1b), using the density, b,
obtained from standard tables and the partial speci¢c volume, X1,
calculated based on the amino acid composition using the published
consensus data [50].
2.6. CD spectroscopy
Protein samples (0.5 mg/ml) were dialyzed against 20 mM NaPi, pH
7.0. CD spectra were recorded using an AVIV 60DS spectropolarim-
eter controlled by AVIV 60DS v4.1i software. The wavelength range
scanned was 300^190 nm. Measurements were made at 25‡C in a
rectangular cuvette of 0.2 mm path length. The data were processed
using the SUPER3 software package described by Wallace and Tee-
ters [51]. Spectra were normalized to the mean residue ellipticity by
applying the scale factor:
0:1UMRW=ð½mg=mlUplÞ
where pl is the cuvette pathlength in centimeters and MRW is the
mean residue weight (molecular weight divided by number of resi-
dues). The spectrum reported in Fig. 4 is the average of four scans
taken at 1 nm/s. Data were corrected for the baselines by subtracting
the data from bu¡er. After data collection, the spectrum was decon-
voluted and data were analyzed for estimation of secondary structure
composition using the Yang reference data [52]. The normalized root
mean square deviation (NRMSD) parameter was calculated to deter-
mine the agreement between the experimental data and the calculated
secondary structure. NRMSD is de¢ned as:
P½ða exp3a calÞ2=ða expÞ21=2
where aexp represents the experimental ellipticity and acal is the el-
lipticity of the back-calculated spectrum for the derived structure [53].
For comparison with the secondary structure of the FepA plug do-
main, the number of residues making up each secondary structure
element was determined and expressed as a percentage of the total
number of residues in the plug domain.
2.7. Nitrocellulose-based transferrin binding assay
The nitrocellulose-based transferrin binding assay has been de-
scribed previously [11]. Brie£y, serial dilutions (1:10) of the samples
were prepared in phosphate-bu¡ered saline (PBS), pH 7.4. Five Wl of
each dilution was blotted onto a nitrocellulose membrane (Bio-Rad),
and left to dry for about 15 min. The membrane was blocked in 25 ml
PBS, pH 7.4, containing 1% (w/v) milk powder for 1 h, with gentle
shaking. The membrane was then washed in 25 ml distilled water,
followed by three 5 min washes in PBS, before being probed with
1 Wg/ml horseradish peroxidase-conjugated hTf (hTf-HRP) for 1 h,
with gentle shaking. Bound hTf-HRP was visualized by the addition
of 4-chloronaphthol (5 Wg/ml) and 0.05% (v/v) H2O2, in PBS. Full-
length TbpA containing an N-terminal His10 tag, prepared essentially
as previously described [54], was used as a control.
2.8. Isothermal titration calorimetry
The titration of TbpA160 with apo- or holo-hTf was carried out on
a VP-ITC Microcalorimeter (Microcal, Northampton, MA, USA). A
description of this instrument, including software and data analysis,
has been provided [55]. Both apo- and holo-hTf were obtained from
Sigma and added to the bu¡er without further puri¢cation. The pro-
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teins were dialyzed against a bu¡er containing 10 mM HEPES bu¡er
pH 7.5, 25 mM NaHCO3, and 200 mM NaCl. Protein samples and
bu¡er were ¢ltered using a 0.22 Wm ¢lter (Millipore). TbpA160 was
loaded into the sample cell (volume=1.4 ml) at concentrations of
5 WM and 10 WM. hTf was loaded into the injection syringe (250 Wl)
and titrated into the sample cell at concentrations of 50 and 75 WM,
respectively. A typical titration series involved a single 1 Wl injection,
followed by 29 injections of 10 Wl titrant. The ¢rst injection was made
over a 2 s interval, and subsequent injections were made over 20 s
intervals. The baseline was allowed to stabilize for 240 s prior to
subsequent additions to permit adequate time for reaction and equil-
ibration. All experiments were performed at 25‡C and the cell was
stirred continuously at 310 rpm. For control experiments, all param-
eters were identical except that TbpA160 was replaced with bu¡er in
the sample cell. The mean of the enthalpies measured from injection
of ligand into bu¡er was subtracted from raw titration data prior to
curve ¢tting using ORIGIN software (Microcal).
3. Results
3.1. Expression of TbpA160 and TbpA160 mutants
Cytoplasmic expression of TbpA160 produced recombinant
protein recoverable from the soluble fraction, with none
found in the insoluble fraction (Fig. 2, lanes 1 and 2). Peri-
plasmic expression of TbpA160 produced soluble protein lo-
calized to the periplasmic fraction, with none found in the
insoluble fraction (data not shown). However, the yield of
protein from cytoplasmic expression was signi¢cantly higher
than that from periplasmic expression (15 mg cytoplasmic
TbpA160 per liter of culture compared with 0.3 mg periplas-
mic TbpA160 per liter of culture) so most experiments were
performed with TbpA160 expressed in the cytoplasm.
Following cell lysis, TbpA160 (expressed in the cytoplasm
or periplasm) was found to be sensitive to proteolysis, with
two partially degraded products accumulating over time (Fig.
2, lane 4). To address this problem, the growth temperature
was reduced from 37‡C to 30‡C, a protease inhibitor cocktail
and 10% (v/v) glycerol were added to all puri¢cation bu¡ers,
and all procedures, including puri¢cation, were carried out at
4‡C. These modi¢cations led to a delay in proteolysis (Fig. 2,
lane 5), with degraded products beginning to accumulate after
48 h for protein stored at both 4‡C and 320‡C. The molec-
ular weights of the degraded products were examined by mass
spectroscopy (data not shown). Two predominant peaks of
9197.5 Da and 8296.25 Da were observed, which suggested
a cleavage site between residues Y75 and S76. As an alterna-
tive approach to prevent proteolysis, three deletion mutations
and one point mutation were separately introduced using site-
directed mutagenesis. All four mutant proteins were expressed
and puri¢ed as described for wild-type TbpA160. The
TbpA160-Y75F and TbpA160-vS76 mutants displayed resis-
tance to proteolysis, even after a 30 day incubation period at
4‡C (Fig. 2, lanes 6 and 7), whereas the TbpA160-vY75 and
TbpA160-vY75S76 mutants exhibited proteolysis identical to
wild-type TbpA160 (results not shown). Unfortunately, all
mutants had a tendency to aggregate and were largely un-
folded as determined by CD spectroscopy (results not shown),
Fig. 3. TbpA160 is monodisperse and monomeric in solution.
A: Sedimentation equilibrium pro¢les shown in terms of ln(A280)
versus the square of the radius (r2) for data collected at 16 000 rpm
and 4‡C. A linear plot corresponding to that expected for the
TbpA160 monomer is shown to illustrate that the sample is mono-
disperse and monomeric. B: Sedimentation equilibrium pro¢le at
16 000 rpm and 4‡C shown as a distribution of A280 at equilibrium.
The results are analyzed for the best single component M1(13X1b)
¢t, shown as a line through the experimental points. The corre-
sponding distribution of the residuals is shown above the plot.
Fig. 2. Expression and puri¢cation of TbpA160. Samples of
TbpA160 expressed in the cytoplasm were electrophoresed on
4^12% Bis-Tris gels (Invitrogen) using MES bu¡er. Lane M, molec-
ular mass marker (15^150 kDa Perfect Protein Marker; Novagen);
lane 1, soluble fraction; lane 2, insoluble fraction; lane 3, nickel col-
umn eluate; Lane 4, gel ¢ltration column eluate; lane 5, TbpA160
after improved preparation (see text for details); lanes 6 and 7,
TbpA160-vS76 and TbpA160-Y75F, respectively, after a 30 day in-
cubation. Arrows indicate TbpA160 proteolytic fragments.
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therefore further characterization of TbpA160 was carried out
using the wild-type protein.
3.2. Analytical ultracentrifugation suggests that TbpA160 is
monomeric and monodisperse
SDS^PAGE analysis (Fig. 2) and gel ¢ltration chromatog-
raphy (results not shown) showed that TbpA160 migrates as a
25 kDa protein, which is somewhat higher than the calculated
value of about 18.3 kDa. We investigated the oligomerization
state of wild-type Tbp160 by performing sedimentation equi-
librium experiments. At all rotor speeds, data were best mod-
eled in terms of a single ideal solute, determined as described
in Section 2. The sample was found to be monodisperse, as
identical values of M1(13X1b) were obtained at all rotor
speeds (Fig. 3). An average value of 4640U120 g/mol for
M1(13X1b) was obtained, corresponding to a measured mo-
lecular mass of 17 230U 450 g/mol. The value obtained is close
to the calculated molecular mass of TbpA160, indicating that
under these conditions the protein is monomeric (Mcalc =
18 248 g/mol, n=0.94U 0.02).
3.3. CD spectroscopy suggests that TbpA160 is a folded protein
The CD spectrum of wild-type TbpA160 (Fig. 4) is charac-
teristic of a folded protein with identi¢able secondary struc-
tural elements. It shows two negative bands at approximately
208 nm and 222 nm (the 208 nm band is more intense) and a
positive band centered at approximately 190^195 nm. These
features are representative of a protein containing both K-heli-
ces and L-strands [56]. Deconvolution of the CD spectrum
indicates that TbpA160 consists of 21% K-helix, 26% L-sheet,
14% L-turn and 39% random coil, with an NRMSD value of
0.067. An NRMSD value 6 0.1 is a strong indication that the
calculated secondary structure actually re£ects the secondary
structure content of the measured protein [57]. The secondary
structure content calculated for the FepA plug domain from
the crystal structure [29] is 19% K-helix and 24% L-sheet,
which suggests that both plug domains share a common
fold. CD spectra for TbpA160 expressed in the periplasm
yielded similar results, indicating that the plug domain is
folded when it is expressed in either cellular compartment
(results not shown).
3.4. TbpA160 does not show detectable binding of hTf
Although puri¢ed full-length TbpA binds both apo- and
holo-hTf as demonstrated by nitrocellulose ligand binding as-
says using hTf-HRP [58], TbpA160 did not show detectable
binding when analyzed by this method. The full-length TbpA
used in our control experiments showed the expected binding
behavior (results not shown).
Full-length TbpA has also been demonstrated to bind hTf
by isothermal titration calorimetry [59]. In these experiments,
puri¢ed TbpA bound either apo- or holo-hTf, with calculated
dissociation constants of 68.9 nM or 3.7 nM for holo- and
apo-hTf, respectively. In both cases, binding was driven by a
large negative enthalpy change, suggesting the formation of
hydrogen bonds, van der Waals forces, and/or electrostatic
interactions, upon association of transporter and ligand. In
contrast, our preparations of puri¢ed TbpA160 showed no
measurable interaction with either apo- or holo-hTf, while
the full-length TbpA we used as a control yielded the expected
calorimetric titrations (results not shown).
4. Discussion
The plug domain of TbpA is similar in sequence to the plug
domains from other structurally characterized TonB-depen-
dent transporters, showing 29% identity and 44% similarity
to the FepA plug domain [28]. Analysis of the FepA plug
domain from the crystal structure [29] showed that it has
characteristics of globular proteins: its surface is hydrophilic,
and it is stabilized by a hydrophobic core formed from its
central four-stranded L-sheet. Its structure suggests that such
a plug domain might be stable when expressed in the absence
of the transmembrane L-barrel. From the sequence similarity
Fig. 4. CD spectrum of wild-type TbpA160 expressed in the cytoplasm. The spectrum shown is the average of four scans, and is representative
of a folded protein, as described in Section 3. Conditions are as described in Section 2.
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between the FepA and TbpA plug domains, we anticipate that
the TbpA plug domain will adopt a similar structure.
The recovery of TbpA160 in the cytoplasmic or periplasmic
fraction, in the absence of solubilizing agents such as deter-
gents, suggests that this plug domain behaves as a soluble,
globular protein that shows no association with the mem-
brane. Soluble protein was also obtained for the expression
of the predominantly unfolded FepA plug domain [47] and
for a shorter TbpA plug domain construct which was not
analyzed for secondary structure content [60]. The anomalous
behavior of TbpA160 seen by size exclusion chromatography
may re£ect the elongated shape of the folded plug domain.
Assessment by analytical ultracentrifugation showed that
TbpA160 is monomeric and monodisperse under experimental
conditions. Secondary structure analysis of TbpA160 by CD
spectroscopy showed that TbpA160 contains very similar per-
centages of K-helix and L-strand to the FepA plug domain, as
determined by X-ray crystallography [29]. Together these re-
sults suggest that TbpA160 adopts a native-like fold when
expressed in the absence of its transmembrane L-barrel.
Proteolysis was observed in TbpA160 upon cell lysis, with a
single proteolytic cleavage site found between residues Y75
and S76 by mass spectrometry. Residues Y75 and S76 are
conserved in all TbpA sequences in pathogenic Neisseria spe-
cies [25,36,61], Actinobacillus pleuropneumoniae (the causative
agent of porcine pleuropneumonia), and Haemophilus in£uen-
zae (which is implicated in various diseases including menin-
gitis and pneumonia) [36,61]. Although not conserved among
all TonB-dependent transporters, these residues precede the
IRG motif, which is conserved in these proteins. A struc-
ture-based sequence alignment of several TonB-dependent
transporters shows that Y75 and S76 in TbpA correspond
to F147 and G148 in FecA and to I72 and D73 in FepA,
respectively [33]. Although the ligand binding site could not
be determined for FepA [29], the FecA structure places the
F147 and G148 residues in a loop involved in forming the
£oor of the binding pocket for citrate and ferric citrate (Fig.
1) [33]. Since no degradation is observed in full-length TbpA
(M. Oke, R.W. Evans and S.K. Buchanan, unpublished re-
sults) it is likely that independent isolation of TbpA160 ex-
poses site(s) that would otherwise be protected by the L-barrel
domain. Nevertheless, the degradation process was delayed
long enough to permit successful characterization of Tbp-
A160. In a related experiment, the empty (plugless) barrel
domain of FhuA showed an increased sensitivity to proteol-
ysis and a decreased thermal stability, whereas wild-type
FhuA (containing both plug and barrel) is protease-resistant
[48]. These experiments suggest that the plug domain stabilizes
and protects the L-barrel, and the barrel also protects the plug
domain.
It was reported that the FepA plug domain is predomi-
nantly unfolded when expressed without its L-barrel [47].
Contrary to this, we found the homologous TbpA plug do-
main to be folded, with well-de¢ned secondary structural ele-
ments similar to the plug domain of the FepA crystal struc-
ture. Previously, FepA and FhuA plugless proteins were
reported to be capable of TonB-dependent ligand transport
[46,62]. However, two groups have recently shown that the
bacterial strains used in these studies, while having (partial)
chromosomal deletions of the investigated transporters, re-
tained chromosomal plug fragments (encoding the plug do-
main plus some residues of the L-barrel). The chromosomal
plug fragments apparently complemented empty barrels ex-
pressed from a plasmid, resulting in functional transport of
ferric ligands [63,64]. According to these authors, the TonB-
dependent transport activity reported for plugless transporters
was due to the subsequent addition of the plug domain by the
host strain. If this is the case, it provides further evidence that
the plug domain is capable of folding independently of the
L-barrel, since it implies that an already folded plug domain
can be incorporated into the separately expressed L-barrel.
The crystal structures of transporter^substrate complexes
show that substrate binding involves a few residues in the
loops of the plug domain and several more residues in the
extracellular loops of the L-barrel [30^34]. The predominantly
unfolded FepA plug domain, independent of the L-barrel, was
reported to bind to ferric enterobactin, although with lower
a⁄nity relative to full-length FepA [47]. In contrast to the
FepA plug results but in agreement with observations made
for a shorter N-terminal TbpA construct [60] we did not ob-
serve any interaction between TbpA160 and hTf. Further-
more, hTf binding was completely abolished in TbpA mutants
with deletions in several putative L-barrel loops [28], suggest-
ing that the N-terminal domain of TbpA is not a signi¢cant
contributor to ligand binding, but the extracellular loops of
the barrel are very important. Since hTf is much larger than
ferric siderophores (80 kDa versus 400^1500 Da), the binding
site on TbpA may be more extensive, involving a greater
number of residues and a larger binding surface, than what
has been seen to date in siderophore transporters.
In conclusion, we have shown that the N-terminal domain
of TbpA is soluble, monodisperse, and most likely correctly
folded in solution, although incapable of binding hTf. Our
results suggest that the two domains of TbpA, and other
TonB-dependent transporters, may fold independently after
translocation across the inner membrane, with subsequent in-
sertion of the folded plug domain into the L-barrel.
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